Mark Lawrence Rubinstein serves as Chief Medical Officer at ACHIEVE LIFE SCIENCES, INC., where they oversee executive responsibilities. Since joining the company, Mark Lawrence Rubinstein has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 28, 2026 involved receiving (via award) 180,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 28, 2026 | ACHV | $0 | Award | 180,000 | $N/A | Discretionary |
Mark Lawrence Rubinstein currently holds 180,000 shares of ACHIEVE LIFE SCIENCES, INC. (ACHV), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Mark Lawrence Rubinstein has been a net neutral trader of ACHV stock. They have purchased $0 and sold $0 worth of shares.
Mark Lawrence Rubinstein's most recent insider trade was on Jan 28, 2026, when they sold 180,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted